Skip to content
lifestyle.tvshowauditions.info
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Tempest Therapeutics
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
February 25, 2026
Tempest Lays Out Strategic Plan to Advance Recently Acquired Dual-Targeting CAR-T Assets
February 12, 2026
Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets
February 10, 2026
Tempest Announces Record Date for Anticipated Dividend Distribution of Warrants to Stockholders
January 20, 2026
←
Previous Page
1
2